Hamilton Thorne Ltd (HTLZF) 0.1041 $HTLZF
Hamilton Thorne Announces Private Placement Unit Offering of Up to CDN$750,000
Marketwire Canada - Wed Oct 22, 3:33PM CDT
Hamilton Thorne Ltd. (TSX VENTURE: HTL) ("Hamilton Thorne" or the "Company"
, a leading provider of precision laser devices and advanced image analysis systems for the fertility, stem cell and developmental biology research markets, today announced that it is proposing to issue, on a non-brokered private placement basis, an aggregate of up to 7,500,000 Units ("Units) at an offering price of CDN$0.10 per Unit for aggregate gross proceeds of up to approximately CDN$750,000 (subject to increase at the discretion of the board of directors) (the "Offering" . Each Unit will consist of one common share (each, a "Common Share" of the Company and one common share purchase warrant (each, a "Warrant" . Each Warrant will provide the holder the right to purchase a Common Share at CDN$0.20 for a period of twelve months following the closing (subject to acceleration in certain circumstances at the Company's sole discretion).
HTL.VN: 0.130 (-0.015)
Hamilton Thorne Announces New CASA Products at 2014 American Society for Reproductive Medicine Meeting
Marketwire Canada - Tue Oct 21, 1:26PM CDT
Hamilton Thorne Ltd. (TSX VENTURE: HTL), a leading provider of precision laser devices and advanced image analysis systems for the fertility, stem cell and developmental biology research markets, today announced a number of product releases at the annual American Society for Reproductive Medicine meeting being held in Honolulu, Hawaii from October 18 to October 22, 2014.
HTL.VN: 0.130 (-0.015)
Hamilton Thorne Announces Record Second Quarter Sales and Fourth Consecutive Quarter of Net Income
Marketwire - Wed Aug 27, 3:16PM CDT
Hamilton Thorne Ltd. (TSX VENTURE: HTL), a leading provider of precision laser devices and advanced image analysis systems for living cell applications in the fertility, stem cell and developmental biology research markets, today reported operational and financial results for the second quarter and six month period ended June 30, 2014.
HTL.VN: 0.130 (-0.015)
Hamilton Thorne Receives Notification of Grant of Patent Right and CFDA Approval to Market Its LYKOS(R) Laser System in China
Marketwire Canada - Wed Jul 16, 7:20AM CDT
Hamilton Thorne Ltd. (TSX VENTURE: HTL), a leading provider of precision laser devices and advanced image analysis systems for the fertility, stem cell and developmental biology research markets, today announced that it has received notice that the China Food and Drug Administration (CFDA) has approved the Company's cutting edge LYKOS(R) for sale to clinical markets in China. Concurrent to this, the Company is pleased to announce it has received a Notification to Grant Patent Right for Invention covering the Modular Laser Assembly that is at the heart of its LYKOS system.
HTL.VN: 0.130 (-0.015)
Hamilton Thorne & Halotech DNA SL to Preview New, Automated DNA Fragmentation Software ESHRE 2014
Marketwire Canada - Fri Jun 27, 8:15AM CDT
Hamilton Thorne Ltd. (TSX VENTURE: HTL), a leading provider of precision laser devices and advanced image analysis systems for the fertility, stem cell and developmental biology research markets, today announced that it will preview its new, automated DNA Fragmentation software at the European Society for Human Reproduction and Embryology meeting to be held in Munich from June 29 to July 2, 2014.
HTL.VN: 0.130 (-0.015)
Hamilton Thorne Announces Annual and Special Meeting Voting Results
Marketwire - Wed Jun 18, 1:29AM CDT
Hamilton Thorne Ltd. (TSX VENTURE: HTL) ("Hamilton Thorne" or the "Company" , a leading provider of precision laser devices and advanced image analysis systems for the fertility, stem cell and developmental biology research market, is pleased to announce that all of the resolutions proposed at its annual general and special meeting of shareholders held on June 16, 2014 (the "Meeting" were duly passed.
HTL.VN: 0.130 (-0.015)
Hamilton Thorne Introduces Comprehensive Suite of Service and Support Offerings
Marketwire Canada - Mon Jun 16, 7:30AM CDT
Hamilton Thorne Ltd. (TSX VENTURE: HTL), a leading provider of precision laser devices and advanced image analysis systems for the fertility, stem cell and developmental biology research markets, today announced the introduction of a comprehensive suite of service plans, preventive maintenance and training offerings to support its hardware and software products.
HTL.VN: 0.130 (-0.015)
Hamilton Thorne Engages Investor Relations Firm
Marketwire Canada - Mon Jun 16, 7:25AM CDT
Hamilton Thorne Ltd. (TSX VENTURE: HTL), a leading provider of precision laser devices and advanced image analysis systems for the fertility, stem cell and developmental biology research markets, today announced that it has engaged Investor Cubed Inc. ("Investor Cubed" to provide investor relations services. Investor Cubed will be focused on increasing investor awareness while introducing Hamilton Thorne to its network of investment contacts.
HTL.VN: 0.130 (-0.015)
Hamilton Thorne Announces Stock Option Grants
Marketwire Canada - Fri Mar 21, 3:16PM CDT
Hamilton Thorne Ltd. (TSX VENTURE: HTL), a leading provider of precision laser devices and advanced image analysis systems for the fertility, stem cell and developmental biology research markets, today announced that it has granted a total of 1,450,000 stock options to purchase common shares pursuant to the Company's incentive stock option plan. The options are exercisable at Cdn$0.05 per share, and expire ten years from the date of grant. A total of 1,100,000 of these options were granted to the Company's Directors, CEO, CTO and CFO. Grants to non-employee Directors vest over three years; grants to employees vest over four years.
HTL.VN: 0.130 (-0.015)
Hamilton Thorne Announces Preliminary 2013 Financial Results
Marketwire - Thu Feb 13, 7:30AM CST
Hamilton Thorne Ltd. (TSX VENTURE: HTL), a leading provider of precision laser devices and advanced image analysis systems for the fertility, stem cell and developmental biology research markets, today reported preliminary selected unaudited financial results for the fourth quarter and year-ended December 31, 2013.
HTL.VN: 0.130 (-0.015), UTMD: 50.28 (-1.71)
Hamilton Thorne Announces Private Placement Unit Offering of Up to CDN$750,000
Marketwire Canada - Wed Oct 22, 3:33PM CDT
Hamilton Thorne Ltd. (TSX VENTURE: HTL) ("Hamilton Thorne" or the "Company"
, a leading provider of precision laser devices and advanced image analysis systems for the fertility, stem cell and developmental biology research markets, today announced that it is proposing to issue, on a non-brokered private placement basis, an aggregate of up to 7,500,000 Units ("Units) at an offering price of CDN$0.10 per Unit for aggregate gross proceeds of up to approximately CDN$750,000 (subject to increase at the discretion of the board of directors) (the "Offering" . Each Unit will consist of one common share (each, a "Common Share" of the Company and one common share purchase warrant (each, a "Warrant" . Each Warrant will provide the holder the right to purchase a Common Share at CDN$0.20 for a period of twelve months following the closing (subject to acceleration in certain circumstances at the Company's sole discretion). HTL.VN: 0.130 (-0.015)
Hamilton Thorne Announces New CASA Products at 2014 American Society for Reproductive Medicine Meeting
Marketwire Canada - Tue Oct 21, 1:26PM CDT
Hamilton Thorne Ltd. (TSX VENTURE: HTL), a leading provider of precision laser devices and advanced image analysis systems for the fertility, stem cell and developmental biology research markets, today announced a number of product releases at the annual American Society for Reproductive Medicine meeting being held in Honolulu, Hawaii from October 18 to October 22, 2014.
HTL.VN: 0.130 (-0.015)
Hamilton Thorne Announces Record Second Quarter Sales and Fourth Consecutive Quarter of Net Income
Marketwire - Wed Aug 27, 3:16PM CDT
Hamilton Thorne Ltd. (TSX VENTURE: HTL), a leading provider of precision laser devices and advanced image analysis systems for living cell applications in the fertility, stem cell and developmental biology research markets, today reported operational and financial results for the second quarter and six month period ended June 30, 2014.
HTL.VN: 0.130 (-0.015)
Hamilton Thorne Receives Notification of Grant of Patent Right and CFDA Approval to Market Its LYKOS(R) Laser System in China
Marketwire Canada - Wed Jul 16, 7:20AM CDT
Hamilton Thorne Ltd. (TSX VENTURE: HTL), a leading provider of precision laser devices and advanced image analysis systems for the fertility, stem cell and developmental biology research markets, today announced that it has received notice that the China Food and Drug Administration (CFDA) has approved the Company's cutting edge LYKOS(R) for sale to clinical markets in China. Concurrent to this, the Company is pleased to announce it has received a Notification to Grant Patent Right for Invention covering the Modular Laser Assembly that is at the heart of its LYKOS system.
HTL.VN: 0.130 (-0.015)
Hamilton Thorne & Halotech DNA SL to Preview New, Automated DNA Fragmentation Software ESHRE 2014
Marketwire Canada - Fri Jun 27, 8:15AM CDT
Hamilton Thorne Ltd. (TSX VENTURE: HTL), a leading provider of precision laser devices and advanced image analysis systems for the fertility, stem cell and developmental biology research markets, today announced that it will preview its new, automated DNA Fragmentation software at the European Society for Human Reproduction and Embryology meeting to be held in Munich from June 29 to July 2, 2014.
HTL.VN: 0.130 (-0.015)
Hamilton Thorne Announces Annual and Special Meeting Voting Results
Marketwire - Wed Jun 18, 1:29AM CDT
Hamilton Thorne Ltd. (TSX VENTURE: HTL) ("Hamilton Thorne" or the "Company"
, a leading provider of precision laser devices and advanced image analysis systems for the fertility, stem cell and developmental biology research market, is pleased to announce that all of the resolutions proposed at its annual general and special meeting of shareholders held on June 16, 2014 (the "Meeting" were duly passed. HTL.VN: 0.130 (-0.015)
Hamilton Thorne Introduces Comprehensive Suite of Service and Support Offerings
Marketwire Canada - Mon Jun 16, 7:30AM CDT
Hamilton Thorne Ltd. (TSX VENTURE: HTL), a leading provider of precision laser devices and advanced image analysis systems for the fertility, stem cell and developmental biology research markets, today announced the introduction of a comprehensive suite of service plans, preventive maintenance and training offerings to support its hardware and software products.
HTL.VN: 0.130 (-0.015)
Hamilton Thorne Engages Investor Relations Firm
Marketwire Canada - Mon Jun 16, 7:25AM CDT
Hamilton Thorne Ltd. (TSX VENTURE: HTL), a leading provider of precision laser devices and advanced image analysis systems for the fertility, stem cell and developmental biology research markets, today announced that it has engaged Investor Cubed Inc. ("Investor Cubed"
to provide investor relations services. Investor Cubed will be focused on increasing investor awareness while introducing Hamilton Thorne to its network of investment contacts. HTL.VN: 0.130 (-0.015)
Hamilton Thorne Announces Stock Option Grants
Marketwire Canada - Fri Mar 21, 3:16PM CDT
Hamilton Thorne Ltd. (TSX VENTURE: HTL), a leading provider of precision laser devices and advanced image analysis systems for the fertility, stem cell and developmental biology research markets, today announced that it has granted a total of 1,450,000 stock options to purchase common shares pursuant to the Company's incentive stock option plan. The options are exercisable at Cdn$0.05 per share, and expire ten years from the date of grant. A total of 1,100,000 of these options were granted to the Company's Directors, CEO, CTO and CFO. Grants to non-employee Directors vest over three years; grants to employees vest over four years.
HTL.VN: 0.130 (-0.015)
Hamilton Thorne Announces Preliminary 2013 Financial Results
Marketwire - Thu Feb 13, 7:30AM CST
Hamilton Thorne Ltd. (TSX VENTURE: HTL), a leading provider of precision laser devices and advanced image analysis systems for the fertility, stem cell and developmental biology research markets, today reported preliminary selected unaudited financial results for the fourth quarter and year-ended December 31, 2013.
HTL.VN: 0.130 (-0.015), UTMD: 50.28 (-1.71)
